Exit

Details of Pharma Disclosure in the UK

Read more

BMI SYSTEM Newsletter – April 2016

The BMI SYSTEM Newsletter of April 2016 has just been published. Click below to take a look: To subscribe:

Read more
Disclosure is coming

Disclosure is coming

By next June, pharmaceutical companies in EFPIA member countries, European Federation of Pharmaceutical Industries and Association, will have to disclose their transfers of value with HCPs and HCOs made in 2015. Pharmexec.com gives an assessment of the situation in Europe: are companies ready for transparency? At what cost? Read the article:

Read more
Canadian pharma companies agree for more transparency

Canadian pharma companies agree for more transparency

Facing controversy over the benefits granted to HCPs by pharmaceutical companies, ten pharma companies based in Canada have agreed to disclose the amounts paid annually to healthcare professionals and organizations. They have, on their own initiative, developed a program for improving transparency in relationships between the industry and HCPs and HCOs. More broadly, the program […]

Read more
Industry and Patients: An Evolving Partnership

Industry and Patients: An Evolving Partnership

Jane Griffiths, Company Group Chairman of Janssen EMEA, explains how the relationship between the industry and patients is evolving. Source: PharmExec To her, pharmaceutical companies are more than ever patient-centric. They are developing solutions and processes to improve interactions with patients. One way this is being done is through greater transparency, with the disclosure of […]

Read more
European pharma companies struggling to meet transparency requirements

European pharma companies struggling to meet transparency requirements

According to a survey carried out by Veeva Systems in 2015[1], more than 60% of pharma companies is not completely ready to meet the EFPIA transparency requirements. From June 2016, all pharma companies in EFPIA member countries, European Federation of Pharmaceutical Industries and Associations, will have to publish their transfers of values to HCPs and […]

Read more
suscribe to BMI SYSTEM newsletter

BMI SYSTEM Newsletter – December 2015

The BMI SYSTEM Newsletter of December 2015 has just been published. To take a look at it click below : To suscribe :

Read more
ABPI Disclosure of payments to healthcare professionals survey

UK Healthcare Professionals Support Transparency on Pharma Payments

On October 12th, the ABPI, the Association of the British Pharmaceutical Industry, published a survey [1] showing that healthcare professionals believe payments received from the pharmaceutical industry should be made public. ​What do HCPs think about public disclosure of payments? According to the poll of more than 500 doctors, nurses, hospital specialists and pharmacists, 87% […]

Read more

Introducing the EFPIA Disclosure Code

Find out more about the EFPIA Disclosure Code:

Read more

How does the UK Bribery Act work alongside self-regulation in the pharmaceutical industry?

Last year, the spotlight came down on a few well-known pharmaceutical companies when allegations of bribery prompted them to rethink the way they interact with healthcare professionals. GlaxoSmithKline, for example, was troubled by allegations of bribery by its Chinese executives: by the end of the 2013, the company announced that it is stopping payments to […]

Read more
Close
Go top